Blood & Cancer

Biosimilars: Gary H. Lyman


 

In episode 02 of Blood & Cancer, Gary H. Lyman, MD, joins David Henry, MD, to discuss biosimilars. Dr. Lyman defines biosimilars, discusses approvals, and gives clinical pearls. And in Clinical Correlation, Ilana Yurkiewicz, MD, talks about what the word “cure” means to you and what it means to patients.
Apple Podcasts
Google Podcasts

Next Article: